Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001567619-22-000661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-05 | 2022-01-03 | BMRN | Alles Mark J | Dir | A - Grant | $0.00 | +2,300 | 2,300 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | A | A | 2,300 | $0.00 | 2,300 | D | — | — | (F1) Restricted stock units granted on January 3, 2022 represent a pro rata share of the 2021 annual award for independent directors and vest on the date immediately prior to the date of the Company's next regular annual meeting of stockholders, the same vesting date for the 2021 annual award for all other independent directors. |